Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-22

Clinical Trial Update: Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

View source ↗

Summary

Compassionate-use program for aldoxorubicin in sarcoma patients is no longer available.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aldoxorubicin (aldoxorubicin)

Snippet

Sponsor: CytRx | Conditions: Sarcoma | Status: NO_LONGER_AVAILABLE